Anika Therapeutics
Focus: Anika Therapeutics is a biotechnology company specializing in small-molecule therapeutics focused on psychiatry, with a pipeline centered on hyaluronic acid-based treatments and orthopedic/aesthetic applications.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Anika Therapeutics?
AI assessmentMid-stage biotech with solid Phase 3 pipeline but shallow hiring signal—suitable for early-career roles but exercise caution on growth trajectory.
Why Work Here
- Multiple Phase 3 programs (4 active) provide near-term clinical catalysts and advancement visibility
- Diversified pipeline across orthopedics, aesthetics, and psychiatry reduces single-indication dependency
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Hyalofast
Defect of Articular CartilageClinical Trials (1)
NCT02659215HyaloFAST Trial for Repair of Articular Cartilage in the Knee
N/AHelp build intelligence for Anika Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.